omega-n-methylarginine has been researched along with lysophosphatidylcholines in 6 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 5,058 | 39 | 976 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kugiyama, K; Murohara, T; Ohgushi, M; Ohta, Y; Sugiyama, S; Yasue, H | 1 |
| Hirayama, T; Kikuchi, K; Ogawa, Y; Tobise, K | 1 |
| Bohrer, A; Hsu, FF; Ma, Z; Ramanadham, S; Turk, J | 1 |
| Cha, YJ; Chang, EA; Kim, CH | 1 |
| Fukaya, T; Okatani, Y; Wakatsuki, A; Watanabe, K | 1 |
| Fukaya, T; Okatani, Y; Taniguchi, K; Wakatsuki, A; Watanabe, K | 1 |
6 other study(ies) available for omega-n-methylarginine and lysophosphatidylcholines
| Article | Year |
|---|---|
LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
Topics: Animals; Arginine; Copper; Coronary Vessels; Dinoprost; Endothelium, Vascular; Humans; Indomethacin; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Nitroglycerin; omega-N-Methylarginine; Oxidation-Reduction; Superoxide Dismutase; Swine; Thrombin; Vasoconstriction; Vasodilation | 1994 |
Mechanism of endothelium-dependent vasorelaxation evoked by lysophosphatidylcholine.
Topics: Animals; Aorta, Thoracic; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Lysophosphatidylcholines; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prostaglandins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1998 |
Studies of the role of group VI phospholipase A2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells.
Topics: Animals; Arachidonic Acid; Cricetinae; Enzyme Inhibitors; Ethylmaleimide; Fatty Acids; Group VI Phospholipases A2; Insulinoma; Interleukin-1; Islets of Langerhans; Lysophosphatidylcholines; Male; Naphthalenes; omega-N-Methylarginine; Phosphodiesterase Inhibitors; Phospholipases A; Phospholipases A2; Phospholipids; Propranolol; Pyrones; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1999 |
Effects of endothelial cells and mononuclear leukocytes on platelet aggregation.
Topics: Animals; Blood Platelets; Cell Communication; Coculture Techniques; Collagen; Endothelium, Vascular; Humans; Indomethacin; Leukocytes, Mononuclear; Lipoproteins, LDL; Lysophosphatidylcholines; omega-N-Methylarginine; Oxidation-Reduction; Platelet Aggregation; Platelet Function Tests; Swine; Time Factors | 2000 |
Attenuation by melatonin of human umbilical arterial vasoconstriction induced by lysophosphatidylcholine.
Topics: Adult; Antioxidants; Catalase; Dose-Response Relationship, Drug; Electrophysiology; Endothelium, Vascular; Enzyme Inhibitors; Female; Free Radical Scavengers; Humans; Lysophosphatidylcholines; Mannitol; Melatonin; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Potassium Chloride; Serotonin; Umbilical Arteries; Vasoconstriction; Vasodilation | 2000 |
Melatonin suppresses lysophosphatidylcholine enhancement of serotonin-induced vasoconstriction in the human umbilical artery.
Topics: Adult; Dose-Response Relationship, Drug; Drug Synergism; Female; Free Radical Scavengers; Humans; Indomethacin; Lysophosphatidylcholines; Mannitol; Melatonin; Muscle, Smooth, Vascular; omega-N-Methylarginine; Pregnancy; Serotonin; Umbilical Arteries; Vasoconstriction | 2000 |